| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |